Search and navigate to colleges and courses
Apply
Scholarships & exams
Fees
₹9,84,000
Placement
98.5%
Avg Package
₹4,70,000
Highest Package
₹8,50,000
Fees
₹9,84,000
Placement
98.5%
Avg Package
₹4,70,000
Highest Package
₹8,50,000
Seats
120
Students
320
Seats
120
Students
320
The curriculum for the Pharmacy program at Malla Reddy University is meticulously designed to provide students with a comprehensive foundation in pharmaceutical sciences, integrating theoretical knowledge with practical applications and industry exposure. The program spans four years, divided into eight semesters, with each semester comprising core courses, departmental electives, science electives, and hands-on laboratory sessions.
From the first year onwards, students are introduced to fundamental subjects such as Chemistry for Pharmacy I and II, Biology for Pharmacy I and II, and Mathematics for Pharmacy I and II. These foundational courses lay the groundwork for understanding molecular structures, biological systems, and mathematical principles essential in pharmaceutical research and practice.
In subsequent semesters, students transition into specialized subjects including Pharmacology I and II, Medicinal Chemistry I and II, Pharmaceutics I and II, and Clinical Pharmacy. Each subject is complemented by laboratory sessions that reinforce theoretical concepts with practical experience, enabling students to apply scientific principles in real-world scenarios.
| Semester | Course Code | Course Title | Credit Structure (L-T-P-C) | Prerequisites |
|---|---|---|---|---|
| 1 | PCH101 | Chemistry for Pharmacy I | 3-0-2-4 | - |
| 1 | PHB101 | Biology for Pharmacy I | 3-0-2-4 | - |
| 1 | PMA101 | Mathematics for Pharmacy I | 3-0-2-4 | - |
| 1 | PPL101 | Practical Laboratory I | 0-0-6-2 | - |
| 2 | PCH201 | Chemistry for Pharmacy II | 3-0-2-4 | PCH101 |
| 2 | PHB201 | Biology for Pharmacy II | 3-0-2-4 | PHB101 |
| 2 | PMA201 | Mathematics for Pharmacy II | 3-0-2-4 | PMA101 |
| 2 | PPL201 | Practical Laboratory II | 0-0-6-2 | PPL101 |
| 3 | PMK301 | Pharmacology I | 3-0-2-4 | - |
| 3 | PMC301 | Medicinal Chemistry I | 3-0-2-4 | - |
| 3 | PPH301 | Pharmaceutics I | 3-0-2-4 | - |
| 3 | PPL301 | Practical Laboratory III | 0-0-6-2 | PPL201 |
| 4 | PMK401 | Pharmacology II | 3-0-2-4 | PMK301 |
| 4 | PMC401 | Medicinal Chemistry II | 3-0-2-4 | PMC301 |
| 4 | PPH401 | Pharmaceutics II | 3-0-2-4 | PPH301 |
| 4 | PPL401 | Practical Laboratory IV | 0-0-6-2 | PPL301 |
| 5 | PMK501 | Clinical Pharmacy | 3-0-2-4 | - |
| 5 | PPA501 | Pharmaceutical Analysis | 3-0-2-4 | - |
| 5 | PRA501 | Regulatory Affairs | 3-0-2-4 | - |
| 5 | PPL501 | Practical Laboratory V | 0-0-6-2 | PPL401 |
| 6 | PMK601 | Toxicology | 3-0-2-4 | - |
| 6 | PMC601 | Natural Product Drug Discovery | 3-0-2-4 | - |
| 6 | PPH601 | Pharmaceutical Biotechnology | 3-0-2-4 | - |
| 6 | PPL601 | Practical Laboratory VI | 0-0-6-2 | PPL501 |
| 7 | PMK701 | Pharmacogenomics | 3-0-2-4 | - |
| 7 | PRA701 | Drug Development & Clinical Trials | 3-0-2-4 | - |
| 7 | PPH701 | Advanced Formulation Techniques | 3-0-2-4 | - |
| 7 | PPL701 | Practical Laboratory VII | 0-0-6-2 | PPL601 |
| 8 | PFE801 | Capstone Project & Thesis | 0-0-12-8 | - |
The department's philosophy on project-based learning emphasizes active engagement, real-world problem-solving, and interdisciplinary collaboration. Students begin working on mini-projects from their second year, progressing to complex capstone research in their final year.
Mini-projects are designed to allow students to explore specific aspects of pharmaceutical sciences under faculty supervision. These projects typically involve literature reviews, experimental design, data collection, and presentation preparation. Evaluation criteria include scientific rigor, creativity, teamwork, and clarity of communication.
The final-year thesis/capstone project represents a significant research endeavor that integrates knowledge from multiple disciplines. Students select topics in consultation with faculty mentors, conduct original research, and present findings at departmental symposiums and conferences. The scope of these projects ranges from developing new drug formulations to investigating clinical outcomes or exploring novel therapeutic targets.